1,047 results on '"Davies, Mary‐Ann"'
Search Results
102. Effect of Baseline Renal Function on Tenofovir-Containing Antiretroviral Therapy Outcomes in Zambia
103. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
104. COVID-19 wave 4 in Western Cape Province, South Africa: Fewer hospitalisations, but new challenges for a depleted workforce
105. Change in profile of COVID-19 deaths in Western Cape Province, South Africa, during the fourth wave
106. Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale
107. Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study.
108. Feasibility of evaluating COVID-19 vaccine effectiveness and variant severity through a routine health information exchange.
109. The epidemiological and clinical characteristics of COVID-19 in a high HIV/TB burden district level hospital setting
110. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa
111. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages in South Africa
112. Evaluation of a Public COVID-19 Dashboard in the Western Cape, South Africa: a tool for communication, trust, and transparency
113. Cohort profile: the Western Cape Pregnancy Exposure Registry (WCPER)
114. Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
115. Effect of antiretroviral therapy care interruptions on mortality in children living with HIV: cohort study from Southern Africa
116. Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children
117. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
118. HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy—Results From the IeDEA Collaboration
119. The cascade of care to prevent mother‐to‐child transmission in Rio de Janeiro, Brazil, 1996–2013: improving but still some way to go
120. Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium
121. Improving estimates of children living with HIV from the Spectrum AIDS Impact Model
122. Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?
123. HIV-associated malignancies in children
124. Implementation of 'Treat‐all' at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey
125. Changes in rapid HIV treatment initiation after national 'treat all' policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis
126. Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model.
127. Hospitalization among infants who initiate antiretroviral therapy before 3 months of age.
128. Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests
129. Mental health, longitudinal ART adherence, and viral suppression among adolescents and adults living with HIV in South Africa: a cohort study
130. Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: a cohort study
131. The SACCESS network for COVID-19 wastewater surveillance: a national collaboration for public health responsiveness
132. The effect of the COVID-19 lockdown on mental health care use in South Africa: an interrupted time series analysis
133. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study
134. Additional file 1 of Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia
135. Promise and Practice of Professional Portfolios.
136. Reflections on the health system response to COVID-19 in the Western Cape Province
137. Through the Looking Glass...Preservice Professional Portfolios.
138. EDITORIAL COMMENTARY: Assessing the Contribution of the Immune Reconstitution Inflammatory Syndrome to Mortality in Developing Country Antiretroviral Therapy Programs
139. Learning...The Beat Goes On.
140. Mentors and School-Based Partnership: Ingredients for Professional Growth.
141. Effect of antiretroviral therapy care interruptions on mortality in children living with HIV
142. Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis
143. Change in profile of COVID-19 deaths in the Western Cape during the fourth wave
144. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
145. The Association of SARS-CoV-2 Infection and Tuberculosis Disease with Unfavorable Treatment Outcomes: A Systematic Review
146. The effect of the COVID-19 lockdown on mental health care use in South Africa: an interrupted time-series analysis
147. Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa
148. Opportunities during COVID-19 towards achieving Universal Health Coverage
149. Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa
150. Life expectancy trends in adults on antiretroviral treatment in South Africa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.